{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:49Z","timestamp":1792785049616,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Kreftforeningen","award":["223197"],"award-info":[{"award-number":["223197"]}],"id":[{"id":"https:\/\/ror.org\/01925vb10","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60008-9","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:50:49Z","timestamp":1782913849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune cell landscape and metabolic gene activity distinguish triple negative from luminal A-like ductal carcinoma in situ"],"prefix":"10.1038","volume":"16","author":[{"given":"Jens Henrik","family":"Norum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Schandiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torill","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorant","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Hekmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Strell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Bergholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"S\u00f8rlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"60008_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41379-019-0204-1","volume":"32","author":"WM Hanna","year":"2019","unstructured":"Hanna, W. M. et al. Ductal carcinoma in situ of the breast: An update for the pathologist in the era of individualized risk assessment and tailored therapies. Modern Pathology 32, 896\u2013915. https:\/\/doi.org\/10.1038\/s41379-019-0204-1 (2019).","journal-title":"Modern Pathology"},{"key":"60008_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv290","volume":"107","author":"M Morrow","year":"2015","unstructured":"Morrow, M. & Katz, S. J. Addressing overtreatment in DCIS: What should physicians do now?. JNCI: Journal of the National Cancer Institute 107, djv290. https:\/\/doi.org\/10.1093\/jnci\/djv290 (2015).","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"60008_CR3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/1097-0142(19951001)76","volume":"76","author":"DL Page","year":"1995","unstructured":"Page, D. L., Dupont, W. D., Rogers, L. W., Jensen, R. A. & Schuyler, P. A. Continued local recurrence of carcinoma 15\u201325 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76, 1197\u20131200. https:\/\/doi.org\/10.1002\/1097-0142(19951001)76 (1995). :7%253C1197::AID-CNCR2820760715%253E3.0.CO;2-0.","journal-title":"Cancer"},{"key":"60008_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","volume":"31","author":"EJ Groen","year":"2017","unstructured":"Groen, E. J. et al. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). The Breast 31, 274\u201383. https:\/\/doi.org\/10.1016\/j.breast.2016.09.001 (2017).","journal-title":"The Breast"},{"key":"60008_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1467664","volume":"15","author":"H Schandiz","year":"2025","unstructured":"Schandiz, H. et al. High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: Significant associations with clinical practice implications. Front Oncol 15, 1467664. https:\/\/doi.org\/10.3389\/fonc.2025.1467664 (2025).","journal-title":"Front Oncol"},{"key":"60008_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u201352. https:\/\/doi.org\/10.1038\/35021093 (2000).","journal-title":"Nature"},{"key":"60008_CR7","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98, 10869\u201374. https:\/\/doi.org\/10.1073\/pnas.191367098 (2001).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"60008_CR8","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.celrep.2016.06.051","volume":"16","author":"R Lesurf","year":"2016","unstructured":"Lesurf, R. et al. Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer. Cell Rep 16, 1166\u201379. https:\/\/doi.org\/10.1016\/j.celrep.2016.06.051 (2016).","journal-title":"Cell Rep"},{"key":"60008_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-020-0167-x","volume":"6","author":"H Bergholtz","year":"2020","unstructured":"Bergholtz, H. et al. Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions. npj Breast Cancer. Nat. Publishing Group. 6, 1\u20139. https:\/\/doi.org\/10.1038\/s41523-020-0167-x (2020).","journal-title":"Nat. Publishing Group."},{"key":"60008_CR10","doi-asserted-by":"publisher","unstructured":"Hutten, S. J. et al. A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression. Cancer Cell. [Internet]\u00a0(2023) [cited 2023 May 2]; https:\/\/doi.org\/10.1016\/j.ccell.2023.04.002","DOI":"10.1016\/j.ccell.2023.04.002"},{"key":"60008_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13277-012-0602-1","volume":"34","author":"S Kurbel","year":"2013","unstructured":"Kurbel, S. In search of triple-negative DCIS: tumor-type dependent model of breast cancer progression from DCIS to the invasive cancer. Tumor Biol. 34, 1\u20137. https:\/\/doi.org\/10.1007\/s13277-012-0602-1 (2013).","journal-title":"Tumor Biol."},{"key":"60008_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10549-012-2123-4","volume":"135","author":"AC Vargas","year":"2012","unstructured":"Vargas, A. C. et al. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Res. Treat. 135, 153\u2013165. https:\/\/doi.org\/10.1007\/s10549-012-2123-4 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"60008_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/jnci\/djy234","volume":"111","author":"C Strell","year":"2019","unstructured":"Strell, C. et al. Impact of Epithelial\u2013Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ. JNCI: J. Natl. Cancer Inst. 111, 983\u2013995. https:\/\/doi.org\/10.1093\/jnci\/djy234 (2019).","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"60008_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2021.12.023","volume":"185","author":"T Risom","year":"2022","unstructured":"Risom, T. et al. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma. Cell 185, 299\u2013310e18. https:\/\/doi.org\/10.1016\/j.cell.2021.12.023 (2022).","journal-title":"Cell"},{"key":"60008_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/annonc\/mdw623","volume":"28","author":"G Pruneri","year":"2017","unstructured":"Pruneri, G. et al. The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast. Ann. Oncol. 28, 321\u2013328. https:\/\/doi.org\/10.1093\/annonc\/mdw623 (2017).","journal-title":"Ann. Oncol."},{"key":"60008_CR16","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-15-0506","volume":"75","author":"MC Abba","year":"2015","unstructured":"Abba, M. C. et al. A Molecular Portrait of High-Grade Ductal Carcinoma In Situ. Cancer Res. 75, 3980\u20133990. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0506 (2015).","journal-title":"Cancer Res."},{"key":"60008_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.4149\/neo_2022_220103N3","volume":"69","author":"HJ Ryu","year":"2022","unstructured":"Ryu, H. J. & Koo, J. S. Glucose and glutamine metabolism-related protein expression in breast ductal carcinoma in situ. neo 69, 630\u2013639. https:\/\/doi.org\/10.4149\/neo_2022_220103N3 (2022).","journal-title":"neo"},{"key":"60008_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1158\/2767-9764.CRC-24-0287","volume":"5","author":"G Mitsa","year":"2025","unstructured":"Mitsa, G. et al. Clinical proteomics reveals vulnerabilities in noninvasive breast ductal carcinoma and drives personalized treatment strategies. Cancer Research Communications 5, 138\u201349. https:\/\/doi.org\/10.1158\/2767-9764.CRC-24-0287 (2025).","journal-title":"Cancer Research Communications"},{"key":"60008_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10549-023-07016-9","volume":"201","author":"H Schandiz","year":"2023","unstructured":"Schandiz, H. et al. Subtypes of high-grade breast ductal carcinoma in situ (DCIS): Incidence and potential clinical impact. Breast Cancer Res Treat 201, 329\u201338. https:\/\/doi.org\/10.1007\/s10549-023-07016-9 (2023).","journal-title":"Breast Cancer Res Treat"},{"key":"60008_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07593-7","volume":"12","author":"Z Selmani","year":"2022","unstructured":"Selmani, Z. et al. Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by immunohistochemistry. Sci Rep 12, 3617. https:\/\/doi.org\/10.1038\/s41598-022-07593-7 (2022).","journal-title":"Sci Rep"},{"key":"60008_CR21","doi-asserted-by":"crossref","unstructured":"Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 27, 1160\u20137. https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2008.18.1370 (2009).","DOI":"10.1200\/JCO.2008.18.1370"},{"key":"60008_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database Hallmark Gene Set Collection. cels. Elsevier ;\u00a01, 417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004 (2015)."},{"key":"60008_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res"},{"key":"60008_CR24","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.ccell.2022.10.021","volume":"40","author":"SH Strand","year":"2022","unstructured":"Strand, S. H. et al. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell 40, 1521-1536e.e7. https:\/\/doi.org\/10.1016\/j.ccell.2022.10.021 (2022).","journal-title":"Cancer Cell"},{"key":"60008_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092653","volume":"15","author":"S Zahari","year":"2023","unstructured":"Zahari, S., Syafruddin, S. E. & Mohtar, M. A. Impact of the cancer cell secretome in driving breast cancer progression. Cancers (Basel) 15, 2653. https:\/\/doi.org\/10.3390\/cancers15092653 (2023).","journal-title":"Cancers (Basel)"},{"key":"60008_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaz0274","volume":"12","author":"M Uhl\u00e9n","year":"2019","unstructured":"Uhl\u00e9n, M. et al. The human secretome. Science Signaling 12, eaaz0274. https:\/\/doi.org\/10.1126\/scisignal.aaz0274 (2019).","journal-title":"Science Signaling"},{"key":"60008_CR27","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/cncr.21069","volume":"103","author":"ME Sanders","year":"2005","unstructured":"Sanders, M. E., Schuyler, P. A., Dupont, W. D. & Page, D. L. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103, 2481\u20134. https:\/\/doi.org\/10.1002\/cncr.21069 (2005).","journal-title":"Cancer"},{"key":"60008_CR28","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/jcp.2005.031252","volume":"59","author":"MR Hussein","year":"2006","unstructured":"Hussein, M. R. & Hassan, H. I. Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: Preliminary observations. Journal of Clinical Pathology 59, 972\u20137. https:\/\/doi.org\/10.1136\/jcp.2005.031252 (2006).","journal-title":"Journal of Clinical Pathology"},{"key":"60008_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/modpathol.2015.158","volume":"29","author":"E Thompson","year":"2016","unstructured":"Thompson, E. et al. The immune microenvironment of breast ductal carcinoma in situ. Modern Pathology 29, 249\u201358. https:\/\/doi.org\/10.1038\/modpathol.2015.158 (2016).","journal-title":"Modern Pathology"},{"key":"60008_CR30","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1158\/1078-0432.CCR-17-0743","volume":"23","author":"S Hendry","year":"2017","unstructured":"Hendry, S. et al. Relationship of the breast ductal carcinoma in situ immune microenvironment with clinicopathological and genetic features. Clinical Cancer Research 23, 5210\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0743 (2017).","journal-title":"Clinical Cancer Research"},{"key":"60008_CR31","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/2159-8290.CD-17-0222","volume":"7","author":"CR Gil Del Alcazar","year":"2017","unstructured":"Gil Del Alcazar, C. R. et al. Immune escape in breast cancer during in situ to invasive carcinoma transition. Cancer Discovery 7, 1098\u2013115. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0222 (2017).","journal-title":"Cancer Discovery"},{"key":"60008_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znae037","volume":"111","author":"G Rask","year":"2024","unstructured":"Rask, G. et al. Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: Case\u2013control study. British Journal of Surgery 111, znae037. https:\/\/doi.org\/10.1093\/bjs\/znae037 (2024).","journal-title":"British Journal of Surgery"},{"key":"60008_CR33","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/s41379-018-0040-8","volume":"31","author":"MS Toss","year":"2018","unstructured":"Toss, M. S. et al. Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast. Modern Pathology 31, 1226\u201336. https:\/\/doi.org\/10.1038\/s41379-018-0040-8 (2018).","journal-title":"Modern Pathology"},{"key":"60008_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/his.13217","volume":"71","author":"I Miligy","year":"2017","unstructured":"Miligy, I. et al. Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ. Histopathology 71, 258\u201368. https:\/\/doi.org\/10.1111\/his.13217 (2017).","journal-title":"Histopathology"},{"key":"60008_CR35","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/his.14865","volume":"82","author":"L Zeng","year":"2023","unstructured":"Zeng, L., Koh, V. C. Y., Chen, X.-Y. & Tan, P. H. Tertiary lymphoid structures in breast ductal carcinoma in situ correlate with adverse pathological parameters. Histopathology 82, 779\u201388. https:\/\/doi.org\/10.1111\/his.14865 (2023).","journal-title":"Histopathology"},{"key":"60008_CR36","doi-asserted-by":"publisher","unstructured":"Li, M. et al. B Cells in Breast Cancer Pathology. Cancers [Internet]. publisher; 15, (2023) [cited 2025 Nov 25]. https:\/\/doi.org\/10.3390\/cancers15051517","DOI":"10.3390\/cancers15051517"},{"key":"60008_CR37","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1158\/0008-5472.CAN-24-3023","volume":"85","author":"X Qin","year":"2025","unstructured":"Qin, X. et al. Single-Cell Expression Analysis of Ductal Carcinoma In Situ Identifies Complex Genotypic\u2013Phenotypic Relationships Altering Epithelial Composition. Cancer Res. 85, 2302\u20132319. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-3023 (2025).","journal-title":"Cancer Res."},{"key":"60008_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13058-025-01990-2","volume":"27","author":"H Bergholtz","year":"2025","unstructured":"Bergholtz, H. et al. B cells and energy metabolism in HER2-positive DCIS: insights into breast cancer progression from spatial-omics analyses. Breast Cancer Res. 27, 44. https:\/\/doi.org\/10.1186\/s13058-025-01990-2 (2025).","journal-title":"Breast Cancer Res."},{"key":"60008_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nature10642","volume":"481","author":"AR Mullen","year":"2012","unstructured":"Mullen, A. R. et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nat. Nat. Publishing Group. 481, 385\u2013388. https:\/\/doi.org\/10.1038\/nature10642 (2012).","journal-title":"Nat. Nat. Publishing Group."},{"key":"60008_CR40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin, P. et al. Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy. Cell. Elsevier. 136, 521\u2013534. https:\/\/doi.org\/10.1016\/j.cell.2008.11.044 (2009).","journal-title":"Cell. Elsevier"},{"key":"60008_CR41","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41598-022-26789-5","volume":"13","author":"L Tian","year":"2023","unstructured":"Tian, L. et al. SLC11A2: a promising biomarker and therapeutic target in ovarian cancer. Sci. Rep. Nat. Publishing Group. 13, 1132. https:\/\/doi.org\/10.1038\/s41598-022-26789-5 (2023).","journal-title":"Sci. Rep. Nat. Publishing Group."},{"key":"60008_CR42","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.3390\/ijms21218363","volume":"21","author":"JX Wang","year":"2020","unstructured":"Wang, J. X. et al. Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity. Int. J. Mol. Sci. Multidisciplinary Digit. Publishing Inst. 21, 8363. https:\/\/doi.org\/10.3390\/ijms21218363 (2020).","journal-title":"Int. J. Mol. Sci. Multidisciplinary Digit. Publishing Inst."},{"key":"60008_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1347166","author":"H Schandiz","year":"2024","unstructured":"Schandiz, H. et al. Low progesterone receptor levels in high-grade DCIS correlate with HER2 upregulation and the presence of invasive components. Front. Oncol. [Internet] Front. https:\/\/doi.org\/10.3389\/fonc.2024.1347166 (2024). [cited 2025 Apr 7];14.","journal-title":"Front. Oncol. [Internet] Front."},{"key":"60008_CR44","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch, A. et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Annals Oncol. Elsevier. 24, 2206\u20132223. https:\/\/doi.org\/10.1093\/annonc\/mdt303 (2013).","journal-title":"Annals Oncol. Elsevier"},{"key":"60008_CR45","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1200\/JCO.22.02864","volume":"41","author":"AC Wolff","year":"2023","unstructured":"Wolff, A. C. et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO\u2013College of American Pathologists Guideline Update. J. Clin. Oncol. 41, 3867\u201372. https:\/\/doi.org\/10.1200\/JCO.22.02864 (2023).","journal-title":"J. Clin. Oncol."},{"key":"60008_CR46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1200\/JCO.2012.43.4134","volume":"31","author":"A Prat","year":"2013","unstructured":"Prat, A. et al. Prognostic Significance of Progesterone Receptor\u2013Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer. J. Clin. Oncol. 31, 203\u20139. https:\/\/doi.org\/10.1200\/JCO.2012.43.4134 (2013).","journal-title":"J. Clin. Oncol."},{"key":"60008_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/tbj.12368","volume":"21","author":"MJ Silverstein","year":"2015","unstructured":"Silverstein, M. J. & Lagios, M. D. Treatment Selection for Patients with Ductal Carcinoma In Situ (DCIS) of the Breast Using the University of Southern California\/Van Nuys (USC\/VNPI) Prognostic Index. Breast J. 21, 127\u201332. https:\/\/doi.org\/10.1111\/tbj.12368 (2015).","journal-title":"Breast J."},{"key":"60008_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174456","volume":"13","author":"H Bergholtz","year":"2021","unstructured":"Bergholtz, H. et al. Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx\u00ae Digital Spatial Profiler. Cancers 13, 4456. https:\/\/doi.org\/10.3390\/cancers13174456 (2021).","journal-title":"Cancers"},{"key":"60008_CR49","unstructured":"NanoString. Introduction to GeoMx Normalization CTA [Internet]. (2020) [cited 2025 Mar 3]. Accessed 3 Mar 2025. https:\/\/nanostring.com\/wp-content\/uploads\/WP_Introduction-to-GeoMx-Normalization-CTA.pdf. Accessed 3."},{"key":"60008_CR50","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing [Internet]. (2024). https:\/\/www.R-project.org\/"},{"key":"60008_CR51","unstructured":"RStudio, T. & RStudio RStudio: Integrated Development for R. PBC, Boston, MA [Internet]. http:\/\/www.rstudio.com\/ (2020)."},{"key":"60008_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis 3e edn. (2016).","edition":"3e"},{"key":"60008_CR53","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btw313 (2016).","journal-title":"Bioinformatics"},{"key":"60008_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. & Walker, S. Fitting Linear Mixed-Effects Models Using lme4. J. Stat. Softw. 67, 1\u201348. https:\/\/doi.org\/10.18637\/jss.v067.i01 (2015).","journal-title":"J. Stat. Softw."},{"key":"60008_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v082.i13","volume":"82","author":"A Kuznetsova","year":"2017","unstructured":"Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. B. lmerTest Package: Tests in Linear Mixed Effects Models. J. Stat. Softw. 82, 1\u201326. https:\/\/doi.org\/10.18637\/jss.v082.i13 (2017).","journal-title":"J. Stat. Softw."},{"key":"60008_CR56","doi-asserted-by":"publisher","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences; 102, 15545\u201350 (2005). https:\/\/doi.org\/10.1073\/pnas.0506580102","DOI":"10.1073\/pnas.0506580102"},{"key":"60008_CR57","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. bioRxiv https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"60008_CR58","unstructured":"Csardi, G. & Nepusz, T. igraph \u2013 Network analysis software [Internet]. [cited 2025 Feb 11]. (2006). https:\/\/igraph.org\/. Accessed 11 Feb 2025."},{"issue":"1","key":"60008_CR59","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41467-022-28020-5","volume":"13","author":"P Danaher","year":"2022","unstructured":"Danaher, P. et al. Advances in mixed cell deconvolution enable quantification of cell types in spatial transcriptomic data. Nat. Commun. 13385. https:\/\/doi.org\/10.1038\/s41467-022-28020-5 (2022).","journal-title":"Nat. Commun."},{"key":"60008_CR60","unstructured":"Griswold, M. & Danaher, P. SpatialDecon [Internet]. Bioconductor. [cited 2025 Feb 11]. http:\/\/bioconductor.org\/packages\/SpatialDecon\/. Accessed 11 Feb 2025."},{"key":"60008_CR61","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucleic Acids Res."},{"key":"60008_CR62","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1038\/s41467-023-37822-0","volume":"14","author":"Y Feng","year":"2023","unstructured":"Feng, Y. et al. Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments. Nat. Commun. Nat. Publishing Group. 14, 2697. https:\/\/doi.org\/10.1038\/s41467-023-37822-0 (2023).","journal-title":"Nat. Commun. Nat. Publishing Group."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60008-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60008-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60008-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:03:49Z","timestamp":1790769829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60008-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60008"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60008-9","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.cels.2015.12.004","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.B. has previously received a research grant by NanoString (CosMx Protein Grant). The other authors do not have a competing interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30274"}}